mProve ziekenhuizen
mProve ziekenhuizen is a Dutch cooperative network of seven top clinical hospitals delivering roughly 18% of Dutch hospital care and collaborating on healthcare innovation, data analytics (mPlify), labor-saving technology (Funxlab), and standardized care pathways funded through IZA transformation agreements.
- Company typePrivate
- Founded2017
- HeadquartersDordrecht, Netherlands
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What mProve ziekenhuizen does
mProve ziekenhuizen is a Dutch cooperative network of seven top clinical (topklinische) hospitals — Albert Schweitzer ziekenhuis, Isala, Jeroen Bosch Ziekenhuis, Máxima MC, Noordwest Ziekenhuisgroep, Rijnstate, and Zuyderland Medisch Centrum — collaborating on healthcare innovation across approximately 18% of Dutch hospital care. Founded in 2017 and headquartered in Dordrecht, mProve operates three thematic programs: Passende Zorg (appropriate care), Arbeidsbesparende Technologie (labor-saving technology, executed via the Funxlab program), and Datagedreven Werken (data-driven working, executed via the mPlify platform). The network collectively employs 35,000+ healthcare professionals and delivers roughly 5 million outpatient appointments annually.
The portfolio is anchored by mPlify, an internal data platform aggregating patient data from all seven hospitals for benchmarking and predictive analytics, and includes clinical and operational products such as AI in de Spreekkamer (ambient AI documentation), AI voor Protocollen (natural-language search over Zenya protocols), Virtual Fracture Care, CVA eCoach, No Show prediction, Robotic Process Automation, BoneView AI radiology, and standardized care pathways for osteoarthritis, atrial fibrillation, pelvic floor disorders, and breast cancer follow-up. mProverij is the monthly knowledge-sharing forum spreading innovations across member hospitals, and artrose.org is a national patient-facing platform. Partnerships span CumuluZ (data integration), Amsterdam UMC and University of Twente (research), Santeon and NOV (orthopedic standards), SPIRIT consortium, and ZonMw/VWS (research subsidies).
The business model is institutional rather than commercial: mProve receives transformation funding through the Integraal Zorg Akkoord (IZA) from health insurers VGZ and Zilveren Kruis (€12.9 million approved for the first project series), supplemented by research grants (e.g., €350,000 from ZonMw for Early Warning Scores research) and member-hospital contributions. Patient-facing revenue flows to the individual member hospitals through standard Dutch basisverzekering reimbursement; mProve itself does not publicly disclose standalone revenue. Governance is composed of the board chairs and staff chairs of the seven member hospitals, with rotating chairmanship; leadership transitioned in 2025–2026 with Nicole Stolk assuming the chair and Hugo Solleveld appointed director effective 1 February 2026.
mProve ziekenhuizen firmographics
Firmographics- Name
- mProve ziekenhuizen
- Legal name
- mProve
- Website
- https://mprove.nu
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- mProve ziekenhuizen is a Dutch cooperative network of seven top clinical hospitals delivering roughly 18% of Dutch hospital care and collaborating on healthcare innovation, data analytics (mPlify), labor-saving technology (Funxlab), and standardized care pathways funded through IZA transformation agreements.
- Ownership category
- akta.pro rank
mProve ziekenhuizen industry classification
Industry- Product category
- Hospital Healthcare Services
- NAICS
- General Medical and Surgical Hospitals (622110)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062)
- akta.pro primary industry
- Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)
- akta.pro secondary industries
- Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD) (HLACAGAG), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE)
Keywords
Where mProve ziekenhuizen is headquartered
LocationHeadquarters
- HQ city
- Dordrecht
- HQ country
- Netherlands
- HQ region
- Europe
Offices15 records
Markets served
mProve ziekenhuizen business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Healthcare Service Delivery: mProve's seven member hospitals provide medical services to patients, funded through standard Dutch healthcare insurance reimbursement (basisverzekering). Revenue comes from treating patients covered by Dutch health insurers.
- Healthcare Transformation Funding (IZA): mProve receives 12.9 million euros in transformation funds from the Integraal Zorg Akkoord (IZA) for implementing transformation projects focused on labor-saving technology and appropriate care. Funding is conditional on achieving defined objectives.
- Research Grants and Subsidies: mProve hospitals receive research funding from organizations such as ZonMw (350,000 EUR for Early Warning Scores research) and VWS ministry (for CumuluZ data infrastructure).
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
mProve ziekenhuizen product offering
Product offeringCore offering
mProve is a collaborative network of seven top clinical hospitals in the Netherlands that jointly develop, pilot, and scale healthcare innovations across three themes: Passende Zorg (appropriate care), Arbeidsbesparende Technologie (labor-saving technology), and Datagedreven Werken (data-driven working). It delivers shared programs in AI-powered consultation documentation, home medication administration, virtual fracture care, stroke digital coaching, predictive no-show modeling, and a unified data platform (mPlify) that enables cross-hospital benchmarking and value-based care pathways.
Product overview
mProve ziekenhuizen is a collaborative network of seven top clinical hospitals in the Netherlands operating as a unified platform for healthcare transformation. The portfolio consists of mPlify as the foundational data platform powering all data-driven initiatives, supported by Funxlab for labor-saving technology innovation and mProverij for cross-hospital knowledge sharing. Key clinical programs include AI in de Spreekkamer (AI-powered speech recognition for consultation documentation), Medicatie@home (home-based medication administration), AI voor Protocollen (natural language protocol search), Virtual Fracture Care (hybrid fracture care via app), CVA eCoach (stroke patient digital coaching), No Show prediction, and multiple value-based care pathways for conditions including osteoarthritis, atrial fibrillation, pelvic floor disorders, and breast cancer follow-up. The network enables hospitals to share learning, benchmark performance, and scale proven innovations across all member institutions.
Differentiator
Problem solved
Functional benefit
Brands
- mPlify: Data platform of the seven mProve hospitals that collects, processes, and analyzes patient data securely to support data-driven healthcare improvement and benchmarking.
- Funxlab
- mProverij
Products and services
- mProve Zorgvernieuwingsnetwerk (Hospital Innovation Network)
Quantifiable outcome
- 50% reduction in outpatient checkups for stroke patients using CVA eCoach
- +5 more outcomes
Companies that use mProve ziekenhuizen
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
mProve ziekenhuizen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
AI capability16 records
Feature8 records
mProve ziekenhuizen partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- Stichting CumuluZ ZorgdatacoreCumuluZ develops a data integration functionality that retrieves and standardizes medical data from various systems. mProve contributes actively to testing and refining CumuluZ functionality in practice. The Dutch Ministry of VWS provides funding to CumuluZ for improving health data availability for patients, providers, and researchers.
- University of Twente (UT Twente)coreCollaboration with UT Twente on Medicatie@home project to determine KPIs for implementation and evaluate organizational models for home medication administration. Researcher Jedidja Lok-Visser from UT Twente and Isala developed quality indicator set for home parenteral medication.
- ReumaNederlandminorCollaboration with ReumaNederland and regional care partners (GPs, physiotherapists) to build regional arthritis networks and consistent information. Jointly developing patient information website artrose.org.
- Nederlandse Orthopaedische Vereniging (NOV)coreCollaboration with NOV and Traumachirurgie NL on Virtual Fracture Care (VFC) for developing uniform, hybrid care pathways for patients with broken ankles. NOV supports standards and guidelines for orthopedic care.
- Traumachirurgie NLcoreCollaboration with Traumachirurgie NL and NOV on Virtual Fracture Care (VFC) hybrid care pathways for trauma patients.
- SanteoncoreCollaboration with Santeon hospitals on Virtual Fracture Care (VFC) for broken ankle patients. Santeon network shares expertise and implementation experience for standardized trauma care.
- PharosminorPharos experts on 'digital care for everyone' collaborated on webinars about low health literacy and digital communication. Experts Chandra Verstappen and Sevde Koca provided guidance on making digital healthcare accessible.
- Amsterdam UMCminorAmsterdam UMC's Department of Epidemiology and Data Science provides supplementary methodological expertise for Early Warning Scores (EWS) research project conducted by four mProve hospitals.
- SPIRIT ConsortiumminormProve is a practical partner in SPIRIT - Technology for Sustainable Care, a national research program where 50+ partners cooperate on technological and social innovations to keep healthcare human. Kick-off held for collaborative research initiatives.
- ACP-coalitieminormProve plays a connecting and pioneering role in the ACP-coalition bringing together regional and national initiatives to accelerate appropriate care through advance care planning. Partners include Regioplatform, RSO Zorgring, Medisch Spectrum Twente, RSO Zuid-Limburg, Nictiz, and IKNL.
- Nederlandse Vereniging voor Gynaecologie en Obstetrie (NVOG)minorGuidelines from NVOG inform the approach for Total Laparoscopic Hysterectomy (TLH) in day treatment for Heavy Menstrual Bleeding. The NVOG provides clinical standards for gynecological procedures.
- Huisartsen (General Practitioners)minorRegional GPs are key partners in care pathways such as pelvic floor care (pessarium referral), arthritis care, and home medication administration. They receive support for stepped care approaches.
- Nederlandse Zorgautoriteit (NZa)coreNZa established a care product description (facultatieve prestatie) for the pessarium care pathway, enabling hospitals to make tariff agreements with health insurers and declar the pathway structurally.
Scale indicators13 records
Recent moves6 records
Expansion highlights6 records
mProve ziekenhuizen competitors and assessment
Company assessmentRegional players
- Karolinska University Hospital: Swedish academic hospital system with a strong focus on digital health, AI deployment, and outcomes research. Comparable to mProve as a Northern European publicly-funded hospital network driving healthcare innovation.
Broad incumbents
- Mayo Clinic: Large integrated US health system operating multiple hospital campuses with a strong focus on data-driven care, clinical innovation, and outcomes measurement. Comparable to mProve as a multi-hospital network using data and AI to standardize care.
- Cleveland Clinic: US multi-hospital health system with strong focus on clinical outcomes, AI-enabled diagnostics, and digital health innovation. Comparable to mProve in deploying AI tools and standardized care pathways across multiple sites.
- Kaiser Permanente: US integrated payer-provider system combining insurance, hospitals, and physician groups with extensive use of EHR data and value-based care. Comparable to mProve as a coordinated network leveraging data and capitated funding to drive transformation.
- Mass General Brigham: US academic health system operating multiple hospitals with extensive research infrastructure and digital health initiatives. Comparable to mProve's combination of top clinical care and joint research programs (e.g., EWS research with Amsterdam UMC).
- Intermountain Healthcare: US non-profit health system operating multiple hospitals with a long-standing focus on data analytics, value-based care, and standardized clinical pathways. Comparable to mProve's mPlify data platform and care pathway work.
- Geisinger Health: US integrated health system known for pioneering value-based care models, EHR-driven innovation, and population health analytics. Comparable to mProve's data-driven care coordination approach.
Others
- ICHOM (International Consortium for Health Outcomes Measurement): Non-profit consortium that defines standard sets for measuring patient outcomes, used by mProve in its osteoarthritis value-based healthcare initiative. Comparable as an ecosystem enabler for value-based care rather than a direct competitor.
- STZ (Samenwerkende Topklinische opleidingsZiekenhuizen): Association of Dutch top clinical teaching hospitals of which all seven mProve member hospitals are members. STZ provides the governance umbrella and innovation framework (including the STZ Innovatieprijs that mProve won in 2022) under which mProve operates.
Direct peers
- Santeon: Collaboration of seven Dutch top clinical hospitals focused on value-based healthcare improvement through shared learning and outcome measurement. Direct comparable to mProve's network model, and explicitly collaborates with mProve on Virtual Fracture Care and other pathways.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
mProve ziekenhuizen social profiles
Digital presencemProve ziekenhuizen financial estimates
Financial estimateRevenue estimate
Valuation estimate
mProve ziekenhuizen leadership team
Management profileNumber of profiles
Profiles15 records
mProve ziekenhuizen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
mProve ziekenhuizen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about mProve ziekenhuizen
What does mProve ziekenhuizen do?
mProve is a collaborative network of seven top clinical hospitals in the Netherlands that jointly develop, pilot, and scale healthcare innovations across three themes: Passende Zorg (appropriate care), Arbeidsbesparende Technologie (labor-saving technology), and Datagedreven Werken (data-driven working). It delivers shared programs in AI-powered consultation documentation, home medication administration, virtual fracture care, stroke digital coaching, predictive no-show modeling, and a unified data platform (mPlify) that enables cross-hospital benchmarking and value-based care pathways.
Is mProve ziekenhuizen a public or private company?
mProve ziekenhuizen is a private company. It is classified as unknown and is currently operating.
When was mProve ziekenhuizen founded?
mProve ziekenhuizen was founded in 2017. It employs 5,001 to 10,000 people.
Where is mProve ziekenhuizen based?
mProve ziekenhuizen is headquartered in Dordrecht, Netherlands, in the Europe region.
How does mProve ziekenhuizen make money?
Three revenue lines are on record. Healthcare Service Delivery is the primary driver. The others are healthcare Transformation Funding (IZA) and research Grants and Subsidies.
Who are mProve ziekenhuizen's main competitors?
Karolinska University Hospital is listed as a regional player. Broad incumbents are Mayo Clinic, Cleveland Clinic, Kaiser Permanente, Mass General Brigham, Intermountain Healthcare and Geisinger Health. Others are ICHOM (International Consortium for Health Outcomes Measurement) and STZ (Samenwerkende Topklinische opleidingsZiekenhuizen). Santeon is listed as a direct peer.
Does mProve ziekenhuizen have an API?
No public API is recorded for mProve ziekenhuizen.
What industry is mProve ziekenhuizen in?
mProve ziekenhuizen's product category is Hospital Healthcare Services. Its primary akta.pro industry code is HLACAHAD, Care Management & Coordination Platforms (case/disease management workflows), with a secondary code of HLACAGAG, Chronic Disease Management Pathways (e.g., diabetes, CHF, COPD). Its NAICS code is 622110 and its SIC code is 8062.